Resultats globals: 1 registres trobats en 0.02 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
10 p, 954.7 KB Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab : results of three randomized, double-blind, placebo-controlled studies / Giménez-Arnau, Ana M 1961- (Universitat Autònoma de Barcelona. Departament de Medicina) ; Spector, Sheldon (California Allergy and Asthma Medical Group, Inc.) ; Antonova, Evgeniya (Medical Affairs, Genentech, Inc.) ; Trzaskoma, Benjamin (Medical Affairs, Genentech, Inc.) ; Rosén, Karin (Medical Affairs, Genentech, Inc.) ; Omachi, Theodore A. (Medical Affairs, Genentech, Inc.) ; Stull, Donald (Data Analytics and Design Strategy, RTI Health Solutions, Manchester) ; Balp, Maria Magdalena (HEOR in Global Patient Access, Novartis Pharma AG) ; Murphy, Thomas (National Allergy, Asthma, and Urticaria Centers of Charleston)
Patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) report difficulty with sleep. We examined the effect of omalizumab on sleep-related outcomes during 3-6 months omalizumab or placebo treatment and a 16-week follow-up period within three Phase III double-blind randomized placebo-controlled pivotal trials in CIU/CSU: ASTERIA I, ASTERIA II, and GLACIAL. [...]
2016 - 10.1186/s13601-016-0120-0
Clinical and translational allergy, Vol. 6 (august 2016)  

Vegeu també: autors amb noms similars
1 Stull, D.E.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.